HB270 Summary

• Amends Alabama's Prescription Drug Monitoring Program (PDMP) law to revise definitions of key terms including pharmacist, practitioner, and pharmacy under Sections 20-2-211 through 20-2-215 of the Alabama Code.

• Creates an Information Release Review Committee to approve requests for release or publication of de-identified aggregate statewide and regional health information for statistical, research, or educational purposes.

• Establishes the Committee composition with five members: one licensed physician, one licensed dentist, one licensed pharmacist, and two representatives experienced in medical informatics or clinical research appointed by the State Health Officer and Attorney General respectively.

• Specifies de-identification standards requiring compliance with federal regulations (45 C.F.R. §164.514(b)(2)) and mandates written data use agreements between requestors and the department before information release.

• Becomes effective on the first day of the third month following passage and approval by the Governor.